Release the flies.
- Published in:
- 2004
- Publication type:
- Editorial
Works matching DE "EXELIXIS Inc."
Results: 12
1
2
Accessing the Exelixis collection.
- Published in:
- 2004
- By:
- Publication type:
- Letter
3
Biomarkers Speeding Cancer Drugs.
- Published in:
- Bio-IT World, 2007, v. 6, n. 7, p. 14
- By:
- Publication type:
- Article
4
News Blast.
- Published in:
- Bio-IT World, 2004, v. 3, n. 11, p. 10
- Publication type:
- Article
5
Market watch: Upcoming catalysts in Q2 2015.
- Published in:
- Nature Reviews Drug Discovery, 2015, v. 14, n. 4, p. 228, doi. 10.1038/nrd4598
- By:
- Publication type:
- Article
6
Deal watch: Bristol–Myers Squibb and Exelixis collaborate on kinase inhibitors.
- Published in:
- Nature Reviews Drug Discovery, 2009, v. 8, n. 2, p. 98, doi. 10.1038/nrd2822
- Publication type:
- Article
7
Exelixis Access Services: EASE.
- Published in:
- 2018
- Publication type:
- Product Review
8
Exelixis slashes 70% of staff.
- Published in:
- Nature Biotechnology, 2014, v. 32, n. 10, p. 966, doi. 10.1038/nbt1014-966c
- Publication type:
- Article
9
Exelixis debuts in rare cancer.
- Published in:
- Nature Biotechnology, 2013, v. 31, n. 2, p. 92, doi. 10.1038/nbt0213-92a
- By:
- Publication type:
- Article
10
Pivotal FDA/Exelixis dispute.
- Published in:
- Nature Biotechnology, 2012, v. 30, n. 1, p. 6, doi. 10.1038/nbt0112-6b
- By:
- Publication type:
- Article
11
Pipeline cherrypicking deal yields lucrative return.
- Published in:
- Nature Biotechnology, 2006, v. 24, n. 7, p. 729, doi. 10.1038/nbt0706-729
- By:
- Publication type:
- Article
12
$100 million pesticide deal.
- Published in:
- Nature Biotechnology, 2000, v. 18, n. 2, p. 132, doi. 10.1038/72505
- By:
- Publication type:
- Article